Patients

A practice focusing on your personal risk of cancer.  Risk analysis and risk stratification for development of personalized medical care are an important part of this practice.  Our goal is to reduce your risk of developing cancer or minimize the impact of a cancer diagnosis.  This practice empowers individuals and families with information and tools that impact survival.

Common misconceptions surrounding genetics and cancer:

  • If I have a cancer predisposition gene, then I have cancer or will have cancer
  • If I have the breast cancer gene, will my daughters be at risk for breast cancer
  • Inherited breast cancer is related to the BRCA gene
  • If I have the BRCA gene, then I am only at risk of developing breast cancer
  • My family has so much cancer, so I know I have the gene
  • My doctor sent me here to see if I have the gene
  • Cancer genes only affect females

Questions often asked:

  • Is there anything I can do to reduce my risk of developing cancer
  • Do the choices I make impact my chances of developing cancer
  • If I have an inherited risk gene are my children and family at risk
  • Does genetic testing tell me if I have cancer anywhere in my body
  • If my results come back positive with an inherited risk gene what happens

This practice embraces knowledge and believes in empowering individuals and families with lifesaving information regarding cancer risk and cancer risk reduction.  This wholistic practice provides care for the individuals and families addressing the physical and psychosocial impact of cancer and inherited risk.

New areas in cancer risk assessment:

  • Solid tumor molecular genetic testing to assist in identifying treatment targets and inherited risk genes
  • Cell free DNA for rapid identification of possible treatment targets
  • Polygenic Risk Scores emerging to assist with establishing individual cancer risk

Insurance

Insurance pays for genetic evaluation of all individuals who meet National Comprehensive Network Guidelines for genetic testing for specific cancers.  If an individual does not meet guidelines and desires genetic evaluation – out of pocket cost is $250.00 or less.  Financial Assistance from the labs may further reduce or eliminate cost.  Ability to afford payment should never hinder anyone from seeking genetic evaluation. Grant funds may be accessible to help with cost of testing.

Free single-site testing – Testing of family members for an identified cancer predisposition gene may be offered free of charge.  

GINA

Genetic Information Non-discrimination Act provides protection for an individual’s health insurance.  An insurer cannot deny or drop an individual based on an abnormal genetic test result – premiums may not be increased, and an insurer may not charge a higher co-pay for surveillance verses diagnostic screenings.  The GINA law guards against workplace discrimination for hire, fire, and promotion.  It safeguards an individual’s and family’s privacy of genetic information.